GSP Crop science Ltd.
Price Range
₹304–320
Issue Size
₹ 286 Cr
Lot Size
46 Shares
Min. Investment
₹ 13,984
Financial Summary
(in crores)| Particulars | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Operating Revenue | 12,873.85 | 11,521.61 |
| Other Income | 136.71 | 60.67 |
| Total Income | 13,010.56 | 11,582.28 |
| Total Expenses | 11,370.23 | 10,278.23 |
| Profit Before Tax | 1,096.81 | 765.56 |
| Total Profit | 814.2 | 555.4 |
Subscription Details
Subscription
IPO Timeline
IPO Offer Start
16 Mar 2026
IPO Offer Ends
18 Mar 2026
Listing Date
24 Mar 2026
Use of Proceeds
| # | Purpose | Amount (₹ Cr) |
|---|---|---|
| 1 | Repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by Our Comp | 1,700 |
| 2 | General corporate purposes | 503.17 |
Promoters
Promoter Shareholding
Pre-IPO
98.25%
Promoter stake
Post-IPO
71.73%
Promoter stake
Offered to Public
89,47,367
shares
Post Share Capital
3,33,65,575
shares
About the Company
We are a research-driven agrochemical company, specializing in the development and manufacturing of insecticides, herbicides, fungicides and plant growth regulators in India, with over 39 years of experience in the agrochemical industry. We provide our customers with crop protection solutions designed to support farmers in maximizing productivity and achieving optimal agricultural output through development, manufacturing, supply and distribution of (i) formulations, which refer to products composed of ‘active ingredients’, chemical compounds in a product responsible for achieving the desired effects on the target pests, weeds, or plant diseases and ‘additives’ which improve the product's performance, stability, and ease of use , in definite proportion obtaining well-defined target properties (“Formulations”); and (ii) technicals, which refer to concentrated form of the ‘active ingredients’ which are processed with other ingredients to develop formulations (“Technicals”).
Use of Proceeds
1. Repayment or pre-repayment of all or a portion of certain outstanding borrowings availed by our Company; and 2. General corporate purposes.